INKT
MiNK Therapeutics, Inc. Common Stock
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Best Biotech Stocks 2026 →
MiNK Therapeutics (INKT) Stock: Buy, Sell, or Hold?
$9.53
-0.69 (-6.79%)
▼
5d:
-5.17%
30d:
-7.92%
90d:
-15.44%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (53%)
Quality Score
43/100
Position
OVERSOLD
30-Day Fair Range
$9.89 – $11.11
Position: OVERSOLD
Forward P/E & Valuation
-13.2x
Next 12M consensus est.
Wall Street Target
$44.00
+361.7% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$9.53 / $11.48
Trend: Downtrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
📊 MIXED SIGNALS: INKT shows conflicting indicators. Wait for confirmation before entering.
Get Alerted When INKT Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: INKT is currently trading at $9.53, which is considered oversold relative to its 30-day fair value range of $9.89 to $11.11.
Technical Outlook: Technically, INKT is in a downtrend. The price is currently testing key support at $9.53. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 6.8% recently.
Market Sentiment: INKT scores 25/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $44.00 (+361.7%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, INKT is in a downtrend. The price is currently testing key support at $9.53. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 6.8% recently.
Market Sentiment: INKT scores 25/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $44.00 (+361.7%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$9.89 -
$11.11
Company Quality Score
43/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
52.6%
Trading Range & Key Levels
30-Day Trading Range
$9.89 -
$11.11
Current vs Trading Range
OVERSOLD
Support Level
$9.53
Resistance Level
$11.48
Current Trend
Downtrend
Technical data as of
Nov 12, 2026
Quantitative Signal Breakdown
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-6.8%)
- BULLISH: Trading 361.7% below Wall St target ($44.00)
- WARNING: Composite score 43/100 in the bottom quintile — this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
-13.24
Wall Street Target
$44.00
(+361.7%)
Share INKT Analysis
Share this live INKT analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (INKT)
Bullish
2 Retail Mentions
Reddit / WSB Comments
1
Bearish
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Nov 11, 2026
Daily AI digest
AI Retail Discussion Summary:
Bullish sentiment on StockTwits regarding $INKT, with mention of a $22 million investment from Dr. Patrick Soon-Shiong and potential billion-dollar opportunities from the ImmunityBio/INKT trial.
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 12, 2026 6:40 PM ET
Data refreshes hourly during market hours. Next update: 7:40 PM
Data refreshes hourly during market hours. Next update: 7:40 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is INKT showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
REGN
Regeneron Pharmaceutical… |
BUY
28 analysts |
$978 | 32 SELL |
|
WVE
Wave Life Sciences Ltd |
STRONG BUY
21 analysts |
$17 | 37 SELL |
|
PRAX
Praxis Precision Medicin… |
STRONG BUY
21 analysts |
$650 | 32 SELL |
|
JAZZ
Jazz Pharmaceuticals PLC |
STRONG BUY
22 analysts |
$296 | 24 SELL |
|
DYN
Dyne Therapeutics Inc |
STRONG BUY
17 analysts |
$34 | 49 HOLD |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive INKT Research Pages
